SCHEMBL6135837

SCHEMBL6135837

O=c1c2nc(-c3cc[c]cc3)[nH]c2n(CC2CCCCC2)c(=O)n1CC1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 4/20 0.46
ADORA2A P29274 3/20 0.46
ADORA2B P29275 3/20 0.46
ADORA3 P0DMS8 2/20 0.46
MTOR P42345 10/20 0.37
PDE5A O76074 3/20 0.36
PDE4A P27815 2/20 0.36
PDE4B Q07343 2/20 0.36
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
PIK3CA P42336 1/20 0.34
ABCC1 P33527 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27566511 0.89 ADORA1 (0.50) ADORA1ADORA2AADORA2BADORA3PDE5A
SCHEMBL6555760 0.85 ADORA1 (0.54) ADORA1ADORA2AADORA2BADORA3MTOR
SCHEMBL6049634 0.85 MTOR (0.51) ADORA1ADORA2AADORA2BADORA3MTOR
SCHEMBL6574184 0.84 ADORA2B (0.53) ADORA1ADORA2AADORA2BADORA3MTOR
SCHEMBL6135707 0.82 ADORA3 (0.41) ADORA1ADORA2AADORA2BADORA3MTOR
SCHEMBL5860152 0.81 ADORA1 (0.50) ADORA1ADORA2AADORA2BADORA3MTOR
SCHEMBL6554017 0.80 ADORA2B (0.63) ADORA1ADORA2AADORA2BADORA3MTOR
SCHEMBL5616732 0.80 ADORA2B (0.74) ADORA1ADORA2AADORA2BADORA3MTOR
SCHEMBL6049579 0.80 ADORA1 (0.43) ADORA1ADORA2AADORA2BADORA3MTOR
SCHEMBL6555076 0.80 ADORA2B (0.74) ADORA1ADORA2AADORA2BADORA3MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0970081-B1 SUBSTITUTED (1,3-BIS(CYCLOHEXYLMETHYL)-1,2,3,6-TETRAHYDRO-2,6-DIOXO-9H-PURIN-8-YL)PHENYL DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF INFLAMMATORY CONDITIONS AND IMMUNE DISORDERS GLAXO GROUP LTD (GB) 2005-09-14 EP disclosed
CN-1140527-C Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl) phenyl derivatives, their preparation and use in treatment of inflammatory conditions and immune disorders 2004-03-03 CN disclosed
US-6437124-B1 XANTHINE DERIVATIVES WHICH INHIBIT EXPRESSION OF ADHESION MOLECULES ON HUMAN UMBILICAL VEIN ENDOTHELIAL CELL (HUVEC) MONOLAYERS AT VERY LOW CONCENTRATIONS SMITHKLINE BEECHAM CORPORATION 2002-08-20 US disclosed
US-6355646-B1 IMMUNOLOGY TREATMENT OF INFLAMMATORY CONDITIONS AND IMMUNE DISORDERS SEPTIC SHOCK GLAXO WELLCOME INC. 2002-03-12 US disclosed
CN-1252071-A Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl) phenyl derivatives, their preparation and use in treatment of inflammatory conditions and immune disorders GLAXO GROUP LTD (GB) 2000-05-03 CN disclosed
EP-0970081-A1 SUBSTITUTED (1,3-BIS(CYCLOHEXYLMETHYL)-1,2,3,6-TETRAHYDRO-2,6-DIOXO-9H-PURIN-8-YL)PHENYL DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF INFLAMMATORY CONDITIONS AND IMMUNE DISORDERS GLAXO GROUP LIMITED (GB) 2000-01-12 EP disclosed
WO-1998035966-A1 SUBSTITUTED (1,3-BIS(CYCLOHEXYLMETHYL)-1,2,3,6-TETRAHYDRO-2,6-DIOXO-9H-PURIN-8-YL)PHENYL DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF INFLAMMATORY CONDITIONS AND IMMUNE DISORDERS GLAXO GROUP LIMITED (GB) 1998-08-20 WO disclosed